Screener
Ionis Pharmaceuticals IONS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Other current assets | 327,011 | 237,092 |
| Total current assets | 2,491,274 | 2,990,635 |
| Property, plant and equipment, net | 155,131 | 123,048 |
| Right-of-use assets | 231,560 | 238,549 |
| Deposits and other assets | 116,536 | 171,604 |
| Total assets | $$2,994,501 | 3,523,836 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's operating lease ROU assets?
- Ionis Pharmaceuticals (IONS) reported operating lease ROU assets of $231.56M in Q2 2026.
- How has Ionis Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Ionis Pharmaceuticals's operating lease ROU assets increased by 41.3% year-over-year, from $163.93M to $231.56M.
- What is the long-term trend for Ionis Pharmaceuticals's operating lease ROU assets?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's operating lease ROU assets has grown at a -99.2% compound annual growth rate (CAGR), from $17.97M to $0.07.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Ionis Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude